GlassScriptPhysician profile
Christopher O Baldwin
NPI 1164483921
$1,072.94
in general payments reported to CMS, 2019-2025
23 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $94.98 · 2021: $115 · 2022: $135 · 2023: $132 · 2024: $185 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $266.36 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $132.60 | 2019-2022 | |
| Amgen INC. | $110.17 | 2019-2024 | Evenity, Prolia |
| Regeneron Healthcare Solutions, INC. | $90.22 | 2024-2025 | Dupixent |
| Grifols USA, LLC | $82.76 | 2019-2025 | Prolastin-C Liquid |
| Otsuka America Pharmaceutical, INC. | $51.25 | 2021-2024 | Rexulti, Abilify Asimtufii |
| Genzyme Corporation | $50.83 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.24 | 2020-2022 | |
| Dexcom, INC. | $27.84 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $24.18 | 2021 | |
| Exeltis, USA INC. | $21.57 | 2023 | Slynd |
| Advanced Respiratory, INC | $19.28 | 2019 | |
| Lundbeck LLC | $18.50 | 2023 | Rexulti |
| Merck Sharp & Dohme LLC | $17.78 | 2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.63 | 2025 | Caplyta |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.18 | 2021 | |
| Minerva Surgical, INC | $14.58 | 2019 | |
| Shire North American Group INC | $14.03 | 2019 | |
| Exact Sciences Corporation | $13.77 | 2023 | Cologuard Collection Kit |
| Electromed, INC. | $13.51 | 2025 | Smartvest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.33 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.33 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.